Fumitremorgin C analogs that reverse mitoxantrone resistance in human colon carcinoma cells

Medicinal Chemistry Research

Volumn 9, Issue 6, 1999, Pages 424-437

  He, Haiyin ^a   Rabindran, Sridhar G ^a   Greenberger, Lee M ^a   Carter, Guy T ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT; PIPERAZINEDIONE;

ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0033382636     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1. R. C. Young, Drug resistance: the clinical problem. In: R. F. Ozols, Ed., Drug Resistance in Cancer Therapy, pp. 1, Boston: Kluwer Academic Press, 1989.
2. 2. M. M. Gottesman and I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochemistry., 62, 385, 1993.
3. 3. S. P. C. Cole, K. E. Sparks, K. Fraser, D. W. Loe, C. E. Grant, G. M. Wilson, and R. G. Deeley, Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902, 1994.
4. 4. L. A. Doyle, W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross, A multidrug resistance transporter from human MCF-7 cancer cells, Proc. Natl. Acad. Sci. USA, 95, 15665, 1998.
5. 5. K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Christensen, M. Braggi, L. Greenberger, M. Dean, T. Fojo, and S. E. Bates, Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes, Cancer Res., 59, 8, 1999.
6. 6. R. Allikmets, L. M. Shriml, A. Hutchinson, V. Romano-Spica, and M. Dean, A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance, Cancer Res., 58, 5337, 1998.
7. 7. B. I. Sikic, G. A. Fisher, B. L. Lum, N. A. Brophy, A. M. Yahanda, K. M. Adler, and J. Halsey, Clinical reversal of multidrug resistance. In: R. F. Ozols, Ed., Drug Resistance in Cancer Therapy, pp. 149, Boston: Kluwer Academic Press, 1989.
8. 8. S. K. Rabindran, H. He, M. Singh, E. Brown, K. I. Collins, T. Annable, and L. M. Greenberger, Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C, Cancer Research, 58, 5850, 1998.
9. 9. R. J. Cole and R. H. Cox, Handbook of Toxic Fungal Metabolites, pp. 355-367, 1981.
10. 10. R. Plate, P. H. H. Herkens, H. Behm, H. C. J. Ottenheijm, Application of an isoxazolidine in a stereoselective approach to the fumitremorgin series, J. Org. Chem. 52, 560, 1987.
11. 11. D. M. Harrison and R. B. Sharma, The formation and intermolecular acylation of a 1,2-dihydro-β-carboline derivative; a model sequence for the total synthesis of fumitremorgins, Tetrahedron Lett., 27, 521, 1986.
12. 12. M. Nakagawa, H. Fukushima, T. Kawate, M. Hongu, S. Kodato, T. Une, M. Taniguchi, and T. Hino, Synthetic approach to the total synthesis of fumitremorgins II, Tetrahedron Lett., 27, 3235, 1986.
13. 13. H. Wang and A. Ganesan, Concise synthesis of cell cycle inhibitor demethoxyfumitremorgin C, Tetrahedron Lett., 38, 4327, 1997.
14. 14. T. Hino, T. Kawate, and M. Nakagawa, A synthesis of so-called fumitremorgin C, Tetrahedron, 45, 1941, 1989.
15. 15. The analogs with equatorial C-12 side-chains, e. g. (5aS, 12S) and (5aR, 12R) isomers, have longer retention time than (5aS, 12R) and (5aR, 12S) isomers, whose C-12 side-chains are axial, on C18 columns with gradient solvent system MeOH/H2O.
16. 16. A. Gruber, C. Peterson, and P. Reizenstein, D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro, Int. J. Cancer, 41, 224, 1988.
17. 17. J. M. Ford, E. P. Bruggemann, I. Pastan, M. M. Gottesman, and W. N. Hait, Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res., 50, 1748, 1990.